# 2025-21174: Second Lab This Week Wants Bulk Controlled Substance License

2025-21174, Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-11-26 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21174
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21174
- Title: Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 54385
- Published: 2025-11-26
- Effective: unknown
- Comments close: 2026-01-26
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Second Lab This Week Wants Bulk Controlled Substance License

## Summary

Irvine Labs, Inc. wants to become a big-time maker of marijuana and related substances for research. People already registered or interested can share their thoughts or ask for a hearing by January 26, 2026. This move could boost research supplies but won’t affect other drug activities or costs right now.

## Abstract

Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Application to Manufacture Schedule I Cannabis: benefit, low. On October 6, 2025, Irvine Labs, Inc. applied to be registered as a bulk manufacturer of Schedule I substances: Marihuana Extract (code 7350), Marihuana (code 7360), and Tetrahydrocannabinols (code 7370). The company says it plans to manufacture bulk active pharmaceutical ingredients for product de…
- Registration Limited to Research Manufacture/Distribution: cost, low. If registered, Irvine Labs would be authorized only to manufacture bulk active pharmaceutical ingredients for product development and to distribute them to DEA-registered researchers; no other activities for these drug codes are authorized.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-21174 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/26/2025-21174/bulk-manufacturer-of-controlled-substances-application-irvine-labs-inc)
- [2025-21174 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-26/pdf/2025-21174.pdf)

## Related
- [Previous: 2025-21173, Importer of Controlled Substances Application: Benuvia Operations, LLC](https://policyrisk.com/federal-register/2025-21173)
- [Next: 2025-21175, Importer of Controlled Substances Application: Irvine Labs, Inc.](https://policyrisk.com/federal-register/2025-21175)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21174 (as of 2026-06-08).
